BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9589479)

  • 1. Oligodendroglioma with signet-ring cell morphology: a case report with an immunohistochemical and ultrastructural study.
    Mikami Y; Shirabe T; Hata S; Watanabe A
    Pathol Int; 1998 Feb; 48(2):144-50. PubMed ID: 9589479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study.
    Matyja E; Taraszewska A; Nagańska E; Zabek M
    Folia Neuropathol; 2001; 39(2):103-10. PubMed ID: 11680631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signet-ring cell oligodendroglioma--report of two cases and discussion of the differential diagnosis.
    Kros JM; van den Brink WA; van Loon-van Luyt JJ; Stefanko SZ
    Acta Neuropathol; 1997 Jun; 93(6):638-43. PubMed ID: 9194905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytic characteristics of oligodendroglioma. Fine structural and immunohistochemical studies of two cases.
    Kamitani H; Masuzawa H; Sato J; Kanazawa I
    J Neurol Sci; 1987 May; 78(3):349-55. PubMed ID: 3585407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin basic protein as a possible marker for oligodendroglioma.
    Tanaka J; Hokama Y; Nakamura H
    Acta Pathol Jpn; 1988 Oct; 38(10):1297-303. PubMed ID: 2464269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
    Herpers MJ; Budka H
    Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic oligodendroglioma with ganglioglioma-like maturation.
    Tanaka Y; Nobusawa S; Yagi S; Ikota H; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2012 Oct; 29(4):221-8. PubMed ID: 22231405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
    Hokama Y; Tanaka J; Nakamura H; Hori T
    No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural characterization of transitional cells in oligodendrogliomas.
    Kros JM; de Jong AA; van der Kwast TH
    J Neuropathol Exp Neurol; 1992 Mar; 51(2):186-93. PubMed ID: 1538242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
    Deininger MH; Weller M; Streffer J; Meyermann R
    Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliosarcoma: an immunohistochemical, ultrastructural and fluorescence in situ hybridization study.
    Horiguchi H; Hirose T; Kannuki S; Nagahiro S; Sano T
    Pathol Int; 1998 Aug; 48(8):595-602. PubMed ID: 9736406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed oligodendroglioma and astrocytoma: fine structural and immunohistochemical studies of four cases.
    Kamitani H; Masuzawa H; Sato J; Kanazawa I
    J Neurol Sci; 1988 Feb; 83(2-3):219-25. PubMed ID: 2451711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of refractile eosinophilic granular cells in oligodendroglial tumors.
    Yoshida T; Nakazato Y
    Acta Neuropathol; 2001 Jul; 102(1):11-9. PubMed ID: 11547945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.
    Dehghani F; Schachenmayr W; Laun A; Korf HW
    Acta Neuropathol; 1998 May; 95(5):493-504. PubMed ID: 9600596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.
    Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA
    Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural characteristics of glial fibrillary acidic protein expression in epoxy resin-embedded human brain tumors.
    Bozóky B; Krenács T; Rázga Z; Erdös A
    Acta Neuropathol; 1993; 86(3):295-301. PubMed ID: 8213089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Observation on oligodendroglioma with light, electron microscopy and immunohistochemistry].
    Hang Z; Chen D; Wei Y
    Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):346-8. PubMed ID: 10374324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.